Skip to content
Clinical Trials – home

Tocotrienol: A Promising Natural Compound for Various Health Conditions

0 / 1
trials open to patients / all trials
1+
Countries

In short

Tocotrienol, a form of vitamin E, is being investigated in various clinical trials for its potential health benefits. These trials are exploring tocotrienol's effects on conditions like cancer, liver disease, bone health, muscle strength, and neurological disorders. Researchers are studying different doses and formulations of tocotrienol to determine its safety, efficacy, and optimal use in various patient populations.

At a glance

Conditions Studied
Breast cancer, pancreatic cancer, liver disease, osteoporosis, muscle health, CADASIL
Dosage Range
200 mg to 800 mg daily, often divided into two doses
Administration
Oral capsules or softgels
Study Durations
Ranging from a few weeks to 3 years
Primary Outcomes
Safety, tolerability, efficacy in specific conditions
Secondary Outcomes
Biomarkers, quality of life, disease progression
Patient Populations
Varies by study, includes healthy subjects and patients with specific conditions

What is Tocotrienol?

Tocotrienol is a natural form of vitamin E that has gained attention in recent years for its potential health benefits. It is often referred to as delta-tocotrienol or vitamin E delta-tocotrienol. Tocotrienols are found in various natural sources, including palm oil and annatto (a plant-based food coloring).

Unlike the more common form of vitamin E (tocopherols), tocotrienols have shown unique properties that make them interesting for medical research. They are known for their strong antioxidant properties, which means they can help protect cells from damage caused by harmful molecules called free radicals.

Potential Health Benefits

Research suggests that tocotrienols may have several potential health benefits:

  • Cancer prevention and treatment: Studies have shown that tocotrienols may have anti-cancer properties, particularly for breast and pancreatic cancers .
  • Liver health: Tocotrienols are being studied for their potential to slow down the progression of liver diseases, including cirrhosis and fatty liver disease.
  • Brain health: Research is ongoing to determine if tocotrienols can help prevent the progression of certain brain disorders, such as CADASIL (a rare genetic disorder affecting blood vessels in the brain).
  • Bone health: Some studies suggest that tocotrienols may help improve bone health in postmenopausal women.
  • Muscle health: Researchers are investigating whether tocotrienols can help maintain muscle strength and function in older women.
  • Weight management: There is ongoing research to determine if tocotrienols can help with weight management and obesity-related issues in postmenopausal women.

Ongoing Research

Several clinical trials are currently underway to better understand the effects of tocotrienols on various health conditions:

  • Breast cancer: A study is investigating whether taking tocotrienols before surgery can help reduce inflammation and oxidative stress in breast cancer patients.
  • Pancreatic cancer: Researchers are studying the safety and effectiveness of tocotrienols in patients with pancreatic tumors.
  • Liver disease: A trial is examining whether tocotrienols can slow down the progression of end-stage liver disease.
  • Brain health: Scientists are investigating if tocotrienols can help prevent the progression of CADASIL, a rare genetic brain disorder.
  • Muscle health in older women: A study is looking at whether tocotrienols can improve muscle strength and function in postmenopausal women.
  • Obesity in postmenopausal women: Researchers are examining the effects of tocotrienols on obesity-related measures in postmenopausal women.

Safety and Dosage

Tocotrienols appear to be generally safe when taken as a dietary supplement. However, as with any supplement, it's important to consult with a healthcare provider before starting to take tocotrienols, especially if you have any existing health conditions or are taking medications.

The dosages used in clinical trials vary depending on the condition being studied. For example:

  • For breast cancer studies: 200 mg twice daily
  • For liver disease studies: 400 mg twice daily
  • For studies in postmenopausal women: 300 mg daily

It's important to note that these dosages are being used in controlled research settings and may not be appropriate for general use. Always follow the dosage recommendations provided by your healthcare provider or as indicated on the product label.

Conclusion

Tocotrienol is a promising natural compound that is being studied for its potential benefits in various health conditions. While early research is encouraging, more studies are needed to fully understand its effects and determine the best ways to use it for different health purposes. As research continues, we may learn more about how tocotrienols can be used to support health and potentially treat certain diseases.

Questions people often ask

Conditions where Tocotrienol is being studied

Each condition opens its own overview and trial list

Trials with Tocotrienol

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).